Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Drug Delivery: Miscellaneous Routes01:22

Drug Delivery: Miscellaneous Routes

Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection,  and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs through the...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Targeting the neuropilin 1/interferon γ axis restores glucocorticoid-suppressed T cell function and rescues bone formation to prevent steroid-induced osteonecrosis.

Bone & joint research·2026
Same author

The Effect of Bearing Surface On the Survival of Cementless and Hybrid Total Hip Arthroplasty: An Analysis of Linked National Joint Registry and Hospital Episode Statistics Data.

JB & JS open access·2026
Same author

mTOR signalling mediates the spinal osteoblast pathotype at the curve apex in adolescent idiopathic scoliosis.

Scientific reports·2026
Same author

Metabolic interactions enable aerobic degradation of the environmental pollutant BDE-47.

The ISME journal·2026
Same author

Trust-driven healthy engagement with conversational AI for mental health support in young adults: a mixed methods study.

Scientific reports·2026
Same author

REPROGRAM: REsilience PROmotion with GeRoprotectors: AssessMent of biological effect: Rationale and protocol for a trial of biological effect.

PloS one·2026

相关实验视频

Updated: Jul 8, 2026

Ameliorating Osteoarthritis in Mice Using Silver Nanoparticles
05:50

Ameliorating Osteoarthritis in Mice Using Silver Nanoparticles

Published on: June 2, 2023

含有药物的纳米粒子用于关节内注射.

Piaopiao Pan1,2, Konstantina Simou3, Yanting Ouyang4

  • 1School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, PR China.

PloS one
|January 16, 2026
PubMed
概括

新型药物装载纳米粒子 (NP) 已开发用于关节内注射 (IAI) 治疗早期关节炎 (OA). 这些NP显著改善了关节滑,并证明了持续的药物释放和出色的生物相容性.

更多相关视频

Ultrasound-Guided Needle Release Combined with Corticosteroid Injection for the Treatment of Supinator Syndrome
05:18

Ultrasound-Guided Needle Release Combined with Corticosteroid Injection for the Treatment of Supinator Syndrome

Published on: May 26, 2023

A Novel Cell Injection Method with Minimum Invasion
06:24

A Novel Cell Injection Method with Minimum Invasion

Published on: April 21, 2023

相关实验视频

Last Updated: Jul 8, 2026

Ameliorating Osteoarthritis in Mice Using Silver Nanoparticles
05:50

Ameliorating Osteoarthritis in Mice Using Silver Nanoparticles

Published on: June 2, 2023

Ultrasound-Guided Needle Release Combined with Corticosteroid Injection for the Treatment of Supinator Syndrome
05:18

Ultrasound-Guided Needle Release Combined with Corticosteroid Injection for the Treatment of Supinator Syndrome

Published on: May 26, 2023

A Novel Cell Injection Method with Minimum Invasion
06:24

A Novel Cell Injection Method with Minimum Invasion

Published on: April 21, 2023

科学领域:

  • 生物材料科学 生物材料科学
  • 纳米技术 纳米技术
  • 类风湿病学 类风湿病学

背景情况:

  • 骨关节炎 (OA) 是一种退行性关节疾病,需要有效的治疗策略.
  • 关节内注射 (IAI) 为关节疾病提供局部药物输送.
  • 目前的IAI配方可能在持续释放和滑增强方面存在局限性.

研究的目的:

  • 开发和描述药物载荷纳米粒子 (NP) 作为早期OA的IAI模型配方.
  • 评估开发的NP在人工关节表面上的滑性能.
  • 评估NP配方的药物释放特征和生物相容性.

主要方法:

  • 使用混合同质化和溶剂蒸发技术制备了装载着塞莱科克西布的纳米粒子.
  • 纳米粒子的表征包括水力动力直径和泽塔电位测量.
  • 使用摩擦测试,石英晶微平衡 (QCM) 和原子力显微镜 (AFM) 评估了滑性.
  • 评估了药物释放动力学和状细胞细胞毒性.

主要成果:

  • 纳米粒子呈现出大约200nm的水力动力直径和负泽塔电位 (~-40mV).
  • 这些NP显著提高了模型关节表面 (不钢和弹性体) 之间的滑.
  • 对NP的表面吸附被确定为改善滑的关键因素.
  • 观察到持续释放塞莱科克西布超过一周,在状细胞测定中具有很好的生物相容性.

结论:

  • 含有药物的纳米颗粒显示出作为一种先进的IAI治疗骨关节炎的配方的希望.
  • 与免费赛莱科克西布相比,NP提供了更好的滑和持续的药物输送.
  • 该配方显示出良好的生物相容性,支持其潜在的治疗应用.